First disease trial for bms-813160 started in 2012
Post# of 148337
(Total Views: 623)
Posted On: 02/08/2021 11:07:54 PM
First disease trial for bms-813160 started in 2012 for diabetes no detailed results. Many of the cancer trials should have had preliminary results several years ago. Nothing heard from those trials. No attempt at a COVID trial. Completely unknown safety profile, small molecule like maraviroc so may have serious side effects like maraviroc or worse like aplaviroc.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼